half life of glp 1 agonists Differential Effects GLP-1 Receptor GLP-1 Receptor Agonists Glucagon-like peptide-1 receptor: mechanisms and
Description
Legal Disclaimer All products on this site are for research and development, laboratory, or analytical use only

While natural GLP-1 rarely causes problems, pharmaceutical GLP-1 agonists commonly cause gastrointestinal side effects including nausea, vomiting, diarrhea, and constipation, particularly during dose escalation

47 SGLT2-I approved in the US for the treatment of T2DM include canagliflozin (Invokana, 2013), dapagliflozin (Farxiga, 2014), and empagliflozin (Jardiance, 2014)

The deal aimed to strengthen Roche's position in the competitive and growing obesity drug market

Aroda VR, Rosenstock J, Terauchi Y, et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al
